SCHEMBL21373571

SCHEMBL21373571

[c]1cncnc1-c1ccc2c(c1)OCO2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 10/20 0.44
CYP1A2 P05177 8/20 0.44
CYP2D6 P10635 8/20 0.44
CYP3A4 P08684 7/20 0.44
CYP2C19 P33261 7/20 0.44
TSHR P16473 5/20 0.44
ALDH1A1 P00352 8/20 0.42
KDM4E B2RXH2 6/20 0.42
POLB P06746 2/20 0.42
LMNA P02545 6/20 0.42
DYRK1A Q13627 4/20 0.42
CLK2 P49760 3/20 0.42
DYRK1B Q9Y463 3/20 0.42
CHEK1 O14757 1/20 0.42
AURKA O14965 1/20 0.42
DAPK3 O43293 1/20 0.42
JAK2 O60674 1/20 0.42
PRKD3 O94806 1/20 0.42
MAP4K4 O95819 1/20 0.42
PAK4 O96013 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7614422 0.75 CLK4 (0.49) CLK4CYP1A2CYP2D6CYP3A4CYP2C19
SCHEMBL30501033 0.71 KDM4E (0.59) CLK4CYP1A2CYP2D6CYP3A4CYP2C19
SCHEMBL20380088 0.71 KDM4E (0.59) CLK4CYP1A2CYP2D6CYP3A4CYP2C19
SCHEMBL21387798 0.68 CLK4 (0.50) CLK4CYP1A2CYP2D6CYP3A4CYP2C19
SCHEMBL22162812 0.67 CA12 (0.58) CYP3A4ALDH1A1KDM4EPOLBLMNA
SCHEMBL6923809 0.67 CA12 (0.54) CLK4TSHRALDH1A1KDM4EPOLB
SCHEMBL21565692 0.66 CLK4 (0.48) CLK4CYP1A2CYP2D6CYP3A4CYP2C19
SCHEMBL22404289 0.66 CLK4 (0.50) CLK4CYP1A2CYP2D6CYP3A4CYP2C19
SCHEMBL22404287 0.66 CYP3A4 (0.48) CLK4CYP1A2CYP2D6CYP3A4CYP2C19
SCHEMBL21373604 0.66 QPCT (0.37) CYP3A4ALDH1A1KDM4EMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3543231-A1 COMPOUNDS FOR TREATING CNS- AND NEURODEGENERATIVE DISEASES ETH Zurich (CH) 2019-09-25 EP claimed
EP-3568133-B1 CELL-PROTECTIVE COMPOUNDS AND THEIR USE ETH ZUERICH (CH) 2023-12-13 EP disclosed
CN-116462666-A Cytoprotective compounds and uses thereof 瑞士苏黎世联邦理工学院 2023-07-21 CN disclosed
EP-3543231-A1 COMPOUNDS FOR TREATING CNS- AND NEURODEGENERATIVE DISEASES ETH Zurich (CH) 2019-09-25 EP disclosed